$ cat ./records/gates-foundation-awards-46-7-million-to-integrate-five-neglected--2006.txt
Gates Foundation Awards $46.7 Million to Integrate Five Neglected Tropical Disease Programs
[RECORD.TXT] · cat --full
In December 2006, the Gates Foundation announced five grants totalling $46.7 million to the Carter Center, Imperial College London, and the Task Force for Child Survival and Development to coordinate integrated mass drug administration against trachoma, lymphatic filariasis, onchocerciasis, schistosomiasis, and soil-transmitted helminths. The grants supported coordinated operational research across more than 20 countries and established the evidence base for the integrated NTD delivery model subsequently adopted by WHO as its global standard approach to controlling all five diseases simultaneously.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates hands his Chief Software Architect title to Ray Ozzie
Next →
Gates Foundation Awards PATH $27.8 Million for HPV Vaccine Demonstration Programs in Four Countries
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.